Error: Could not add to watchlist. X
+ Watchlist

ArQule Inc

ARQL:US
NASDAQ GM
1.17
USD
0.03
2.63%
As of 8:10 PM EDT 6/23/2017
Open
1.18
Day Range
1.14 - 1.19
Volume
93,700
Previous Close
1.14
52Wk Range
0.92 - 2.17
1 Yr Return
-38.74%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
1.18
Day Range
1.14 - 1.19
Volume
93,700
Previous Close
1.14
52Wk Range
0.92 - 2.17
1 Yr Return
-38.74%
YTD Return
-7.14%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.36
Market Cap (m USD)
83.242
Shares Outstanding (m)
71.147
Price/Sales (TTM)
23.89
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
ArQule Inc. develops cancer therapeutics based on its proprietary Activated Checkpoint Therapy platform. The Company's platform is designed to produce small molecule compounds that selectively kill cancer cells while leaving normal cells unharmed. ArQule's products are intended to be effective against multiple types of cancer.
Address
19 Presidential Way
Woburn, MA 01801-5140
United States
Phone
1-781-994-0300
  • Paolo Pucci
    Chief Executive Officer
  • Peter S Lawrence
    President/COO/Secy/Gen Cnsl
  • Robert J Weiskopf
    CFO/Treasurer
  • Brian Schwartz
    Senior VP/Chief Medical Ofcr
  • Dawn Schottlandt
    Senior Dir:Investor Relations
Show More